[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine

C14H19BrN4O2 — CID 114961309

IUPAC[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine
SMILESCC1CCN(Cc2nnc(-c3ccc(Br)o3)o2)CC1CN
InChIInChI=1S/C14H19BrN4O2/c1-9-4-5-19(7-10(9)6-16)8-13-17-18-14(21-13)11-2-3-12(15)20-11/h2-3,9-10H,4-8,16H2,1H3
InChIKeyWSMZLPNUIQIHKM-UHFFFAOYSA-N
MW355.24 g/mol
LogP2.51
Rot. Bonds4

About [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine

[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine (PubChem CID 114961309) has the molecular formula C14H19BrN4O2 and a molecular weight of 355.24 g/mol. Its IUPAC name is [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine.

Molecular Properties

Compound Name[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine
PubChem CID114961309
Molecular FormulaC14H19BrN4O2
Molecular Weight355.24 g/mol
Exact Mass354.07
IUPAC Name[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine
SMILESCC1CCN(Cc2nnc(-c3ccc(Br)o3)o2)CC1CN
InChIInChI=1S/C14H19BrN4O2/c1-9-4-5-19(7-10(9)6-16)8-13-17-18-14(21-13)11-2-3-12(15)20-11/h2-3,9-10H,4-8,16H2,1H3
InChIKeyWSMZLPNUIQIHKM-UHFFFAOYSA-N
XLogP2.51
TPSA81.32 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms21
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.24
LogP ≤ 52.51
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine?
The IUPAC name of [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine (CID 114961309) is [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine.
What is the SMILES notation for [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine?
The canonical SMILES for [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine is CC1CCN(Cc2nnc(-c3ccc(Br)o3)o2)CC1CN.
What is the InChIKey of [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine?
The InChIKey is WSMZLPNUIQIHKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H19BrN4O2/c1-9-4-5-19(7-10(9)6-16)8-13-17-18-14(21-13)11-2-3-12(15)20-11/h2-3,9-10H,4-8,16H2,1H3.
What are the key properties of [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine?
[1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine has a molecular weight of 355.24 g/mol, XLogP of 2.51, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[[5-(5-bromofuran-2-yl)-1,3,4-oxadiazol-2-yl]methyl]-4-methylpiperidin-3-yl]methanamine is sourced from PubChem (CID 114961309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).